Header cover image

Italian Pharmaceuticals & Biotech Sustainable Track Record

Results

1

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

Philogen

Market Cap: €1.0b

A biotechnology company, engages in the research and development of drugs for oncology and chronic inflammatory diseases in Italy, Switzerland, the United States, and the European Union.

PHIL

€25.60

7D

7.8%

1Y

22.5%